Rapid autopsy biorepository to advance pancreatic and prostate cancer research
Official title: Critical Resources Provided by UNMC Rapid Autopsy Program (RAP) Biorepository Stimulate Cancer Research
Funded at University of Nebraska Medical Center · NIH-11447692 · Data updated 2026-11-12
A special program collects high-quality tissues and body fluids within 5 hours of death to support pancreatic and prostate cancer research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project start | September 16, 2016 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $95,609 |
| NIH project number | 2R50CA211462-11 |
| Project ID | NIH-11447692 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients who have pancreatic or prostate cancer and have recently passed away may contribute tissue and fluid samples to the RAP biorepository.
✕Less likely to help
Direct patient benefit is not immediate; the program benefits future patients through improved research materials.
What this research studies
This grant supports UNMC’s Rapid Autopsy Program (RAP), which collects fresh patient tissues and fluids from individuals who have died of pancreatic or prostate cancer. The goal is to preserve cellular and molecular integrity so researchers can study cancer across all disease stages. Tissues are archived and distributed to researchers through the university’s cancer programs, helping advance understanding and potential treatments. The program involves coordinated teams and collaboration with multiple cancer research efforts at UNMC to maximize impact.
Why it matters
Potential benefit: Advances in understanding pancreatic and prostate cancer could lead to new therapies and diagnostic approaches for patients.
How similar studies have gone: Other rapid autopsy programs have successfully provided high-quality tissues for cancer research, supporting ongoing discoveries.
Where this research is happening
-
University of Nebraska Medical Center
Omaha, United States Active
Researchers
- Principal investigator: Grandgenett, Paul M — University of Nebraska Medical Center
- Study coordinator: Grandgenett, Paul M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.